ATE275383T1 - Oxadisäuren und verwandte verbindungen zur behandlung von hautstörungen - Google Patents

Oxadisäuren und verwandte verbindungen zur behandlung von hautstörungen

Info

Publication number
ATE275383T1
ATE275383T1 AT97924518T AT97924518T ATE275383T1 AT E275383 T1 ATE275383 T1 AT E275383T1 AT 97924518 T AT97924518 T AT 97924518T AT 97924518 T AT97924518 T AT 97924518T AT E275383 T1 ATE275383 T1 AT E275383T1
Authority
AT
Austria
Prior art keywords
oxadic
acids
treatment
related compounds
skin disorders
Prior art date
Application number
AT97924518T
Other languages
English (en)
Inventor
Dmitri Ptchelintsev
Neil Scancarella
Robert Kalafsky
Original Assignee
Avon Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Avon Prod Inc filed Critical Avon Prod Inc
Application granted granted Critical
Publication of ATE275383T1 publication Critical patent/ATE275383T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/66—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
    • C07C69/67—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of saturated acids
    • C07C69/708—Ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/35—Ketones, e.g. benzophenone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A61K8/362—Polycarboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A61K8/365—Hydroxycarboxylic acids; Ketocarboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/63—Steroids; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/671—Vitamin A; Derivatives thereof, e.g. ester of vitamin A acid, ester of retinol, retinol, retinal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/68—Sphingolipids, e.g. ceramides, cerebrosides, gangliosides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/007—Preparations for dry skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/235—Saturated compounds containing more than one carboxyl group
    • C07C59/305—Saturated compounds containing more than one carboxyl group containing ether groups, groups, groups, or groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/20—Chemical, physico-chemical or functional or structural properties of the composition as a whole
    • A61K2800/24—Thermal properties
    • A61K2800/244—Endothermic; Cooling; Cooling sensation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/52—Stabilizers
    • A61K2800/522—Antioxidants; Radical scavengers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Dermatology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Medicinal Preparation (AREA)
AT97924518T 1996-04-25 1997-04-25 Oxadisäuren und verwandte verbindungen zur behandlung von hautstörungen ATE275383T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/636,540 US5834513A (en) 1996-04-25 1996-04-25 Oxa diacids and related compounds for treating skin conditions
PCT/US1997/006973 WO1997039726A1 (en) 1996-04-25 1997-04-25 Oxa diacids and related compounds for treating skin conditions

Publications (1)

Publication Number Publication Date
ATE275383T1 true ATE275383T1 (de) 2004-09-15

Family

ID=24552353

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97924518T ATE275383T1 (de) 1996-04-25 1997-04-25 Oxadisäuren und verwandte verbindungen zur behandlung von hautstörungen

Country Status (10)

Country Link
US (1) US5834513A (de)
EP (1) EP0910331B1 (de)
JP (1) JP3779733B2 (de)
CN (1) CN1139375C (de)
AR (1) AR006867A1 (de)
AT (1) ATE275383T1 (de)
BR (1) BR9708747A (de)
CA (1) CA2251746C (de)
DE (1) DE69730604T2 (de)
WO (1) WO1997039726A1 (de)

Families Citing this family (84)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5932229A (en) * 1996-04-25 1999-08-03 Avon Products, Inc. Oxa diacids and related compounds for treating skin conditions
GB9610122D0 (en) * 1996-05-15 1996-07-24 Reckitt & Colmann Prod Ltd Organic compositions
US5847003A (en) * 1996-06-04 1998-12-08 Avon Products, Inc. Oxa acids and related compounds for treating skin conditions
FR2761601A1 (fr) * 1997-04-04 1998-10-09 Oreal Compositions cosmetiques autobronzantes
US8039026B1 (en) 1997-07-28 2011-10-18 Johnson & Johnson Consumer Companies, Inc Methods for treating skin pigmentation
US6383495B1 (en) * 1997-12-08 2002-05-07 Council Of Scientific & Industrial Research Herbal formulation useful for treatment of skin disorders
EP1061913B1 (de) * 1998-03-13 2007-06-27 The Johns Hopkins University School Of Medicine Verwendung von einem protein kinase hemmer wie z.b. genistein bei der behandlung von diabetischer retinopathie
EP1063966A1 (de) * 1998-03-16 2001-01-03 The Procter & Gamble Company Zusammensetzung für die regelung des hautaussehens
AU3573399A (en) * 1998-04-29 1999-11-16 Avon Products Inc. Skin whitening composition
US8093293B2 (en) 1998-07-06 2012-01-10 Johnson & Johnson Consumer Companies, Inc. Methods for treating skin conditions
US8106094B2 (en) 1998-07-06 2012-01-31 Johnson & Johnson Consumer Companies, Inc. Compositions and methods for treating skin conditions
US6136339A (en) 1998-08-21 2000-10-24 Gardiner; Paul T. Food supplements and methods comprising lipoic acid and creatine
FR2782922B1 (fr) * 1998-09-09 2002-07-19 Oreal Composition contenant de l'uree et ses utilisations dans le domaine cosmetique et/ou dermatologique
US20040131579A1 (en) * 1998-09-10 2004-07-08 Avon Products, Inc. Method and compositions for reducing dermatological aging and for reducing bruising
CA2309179A1 (en) * 1998-09-10 2000-03-16 Avon Products, Inc. Method and composition for reducing dermatological aging and for reduci ng bruising
US6521237B2 (en) * 1998-11-12 2003-02-18 Johnson & Johnson Consumer Companies, Inc. Skin care composition
WO2000057876A1 (en) * 1999-03-26 2000-10-05 Lipogenics, Inc. Novel antioxidant formulations and methods for using them
EP1055408A1 (de) * 1999-05-26 2000-11-29 Nutrinova Nutrition Specialties & Food Ingredients GmbH Sorbatkonservierte Mittel, Verfahren zu deren Herstellung und ihre Verwendung
US6200964B1 (en) * 1999-05-28 2001-03-13 Neutrogena Corporation Silicone gel containing salicylic acid
US6242491B1 (en) * 1999-06-25 2001-06-05 Rima Kaddurah-Daouk Use of creatine or creatine compounds for skin preservation
US6989163B2 (en) * 2001-10-23 2006-01-24 40 J's Llc Arrangement to enhance a woman's sexual sensitivity by a combination of phytoestrogens, L-arginine and menthol
US7985404B1 (en) 1999-07-27 2011-07-26 Johnson & Johnson Consumer Companies, Inc. Reducing hair growth, hair follicle and hair shaft size and hair pigmentation
US6309662B1 (en) * 1999-09-23 2001-10-30 Janet Buchanan Use of anti-inflammatory drugs for treatment of dermatological conditions
US6358517B1 (en) 1999-10-22 2002-03-19 Unilever Home & Personal Care Usa, Division Of Conopco Cosmetic compositions containing resveratrol and retinoids
US6277362B1 (en) 1999-10-26 2001-08-21 Isw, Inc. After shave treatment preparation
US7309688B2 (en) * 2000-10-27 2007-12-18 Johnson & Johnson Consumer Companies Topical anti-cancer compositions and methods of use thereof
US6645520B2 (en) 1999-12-16 2003-11-11 Dermatrends, Inc. Transdermal administration of nonsteroidal anti-inflammatory drugs using hydroxide-releasing agents as permeation enhancers
US6562370B2 (en) 1999-12-16 2003-05-13 Dermatrends, Inc. Transdermal administration of steroid drugs using hydroxide-releasing agents as permeation enhancers
US6562368B2 (en) * 1999-12-16 2003-05-13 Dermatrends, Inc. Transdermal administration of oxybutynin using hydroxide-releasing agents as permeation enhancers
US6673363B2 (en) 1999-12-16 2004-01-06 Dermatrends, Inc. Transdermal and topical administration of local anesthetic agents using basic enhancers
US6586000B2 (en) * 1999-12-16 2003-07-01 Dermatrends, Inc. Hydroxide-releasing agents as skin permeation enhancers
US20030104041A1 (en) * 1999-12-16 2003-06-05 Tsung-Min Hsu Transdermal and topical administration of drugs using basic permeation enhancers
US6582724B2 (en) 1999-12-16 2003-06-24 Dermatrends, Inc. Dual enhancer composition for topical and transdermal drug delivery
US6565879B1 (en) 1999-12-16 2003-05-20 Dermatrends, Inc. Topical and transdermal administration of peptidyl drugs with hydroxide-releasing agents as skin permeation enhancers
US6562369B2 (en) 1999-12-16 2003-05-13 Dermatrends, Inc. Transdermal administration of androgenic drugs hydroxide-releasing agents as permeation enhancers
US6558695B2 (en) * 1999-12-16 2003-05-06 Dermatrends, Inc. Topical and transdermal administration of peptidyl drugs using hydroxide releasing agents as permeation enhancers
DE19961934A1 (de) * 1999-12-22 2001-06-28 Henkel Kgaa Blondiermittel
FI111686B (fi) * 2000-04-20 2003-09-15 Simo Rasi Kosmeettinen tai ihonhoidollinen voidekoostumus, sen valmistusmenetelmä ja käyttö
DE10032964B4 (de) * 2000-07-06 2017-10-12 Beiersdorf Ag Verwendung von Kreatin in kosmetischen oder dermatologischen Zubereitungen
US8431550B2 (en) 2000-10-27 2013-04-30 Johnson & Johnson Consumer Companies, Inc. Topical anti-cancer compositions and methods of use thereof
US6583184B1 (en) 2000-11-27 2003-06-24 Avon Products, Inc. Compositions having comfrey and methods for reducing retinoid-induced skin irritation
US20040067245A1 (en) 2000-12-20 2004-04-08 Harish Mahalingam Cosmetic compositions and methods for using same to improve the aesthetic appearance of skin
US6565864B2 (en) * 2000-12-28 2003-05-20 Unilever Home & Personal Care Usa, A Division Of Conopco, Inc. Skin care product containing retinoids and phytoestrogens in a dual compartment package
US7192615B2 (en) 2001-02-28 2007-03-20 J&J Consumer Companies, Inc. Compositions containing legume products
US7820688B2 (en) * 2001-04-27 2010-10-26 Memorial Sloan-Kettering Cancer Center Topical anesthetic/opioid formulations and uses thereof
DE10126501A1 (de) * 2001-05-30 2002-12-12 Aventis Pharma Gmbh Zubereitung zur Entfernung von abnormen Keratinmaterial
DE10129504A1 (de) * 2001-06-19 2003-01-09 Beiersdorf Ag Verwendung von Carnitin und/oder einem oder mehreren Acyl-Carnitinen zur Herstellung von kosmetischen oder dermatologischen Zubereitungen zur Behandlung und/oder Prophylaxe von Pigmentierungsstörungen
DE10129502A1 (de) * 2001-06-19 2003-01-09 Beiersdorf Ag Verwendung von Carnitin und/oder einem oder mehreren Acyl-Carnitinen zur Herstellung von kosmetischen oder dermatologischen Zubereitungen zur Steigerung der Ceramidbiosynthese
DE10133198A1 (de) * 2001-07-07 2003-01-23 Beiersdorf Ag Kreatin enthaltende kosmetische und dermatologische Zubereitungen zur Behandlung und aktiven Prävention trockener Haut und anderer negativer Veränderungen der physiologischen Homöostase der gesunden Haut
DE10133200A1 (de) 2001-07-07 2003-01-23 Beiersdorf Ag Carnitin enthaltende kosmetische und dermatologische Zubereitungen zur Behandlung und aktiven Prävention trockener Haut und anderer negativer Veränderungen der physiologischen Homöostase der gesunden Haut
US6641824B2 (en) * 2001-11-09 2003-11-04 Avon Products, Inc. Skin treatment using a new retinoid
US6866856B2 (en) * 2002-12-31 2005-03-15 Avon Products, Inc. Compositions and delivery methods for the treatment of wrinkles, fine lines and hyperhidrosis
US7060303B2 (en) * 2002-12-31 2006-06-13 Avon Products, Inc. Use of purslane to treat facial wrinkles
EP1444969B1 (de) * 2003-02-05 2011-08-31 Kao Corporation Absorbierender Artikel
EP1444970B1 (de) * 2003-02-05 2011-08-17 Kao Corporation Absorbierender Artikel
CA2543540A1 (en) * 2003-10-29 2005-06-02 Johnson & Johnson Consumer France S.A.S. Compositions comprising soy products and dioic acids
DE10355716A1 (de) * 2003-11-26 2005-06-23 Beiersdorf Ag Kosmetische Zubereitungen mit einem Gehalt Kreatin und/oder Kreatinderivaten und/oder Kreatinin und/oderKreatininderivaten und organischen Verdickern
DE10355715A1 (de) * 2003-11-26 2005-06-16 Beiersdorf Ag Wirkstoffkombinationen Kreatin und/oder Kreatinderivaten und/oder Kreatinin und/oder Kreatininderivaten und einer wirksamen Menge an Retinoiden, insbesondere Retinol bzw. Retinylpalmitat und Zubereitungen, solche Wirkstoffkombinationen enthaltend
DE10355714A1 (de) * 2003-11-26 2005-06-30 Beiersdorf Ag Wirkstoffkombination aus Kreatin und/oder Kreatinin, Phenoxyethanol und gewünschtenfalls Glycerin
US20050136015A1 (en) * 2003-12-17 2005-06-23 McKie Derrick B. Topical use of halosalicylic acid derivatives
US7504385B2 (en) * 2003-12-17 2009-03-17 Avon Products, Inc. si-RNA-mediated gene silencing technology to inhibit tyrosinase and reduce pigmentation
DE102004060314A1 (de) * 2004-12-08 2006-08-31 Beiersdorf Ag Wirkstoffkombinationen aus einem oder mehreren Isoflavonoiden und Carnitin und/oder einem oder mehreren Acyl-Carnitinen
US7514092B2 (en) 2004-12-22 2009-04-07 Avon Products, Inc. Compositions and methods of their use for improving the condition and appearance of skin
US7351745B2 (en) 2004-12-22 2008-04-01 Avon Products, Inc Compositions and methods of their use for improving the condition and appearance of skin
US7618662B2 (en) 2004-12-22 2009-11-17 Avon Products, Inc Use of natural plant extracts in cosmetic compositions
US8221766B2 (en) * 2004-12-22 2012-07-17 Avon Products, Inc. Use of plant extracts to prevent and/or reduce the signs of subjective discomfort and/or irritation in the topical application of cosmetic products
US7410658B2 (en) * 2004-12-22 2008-08-12 Avon Products, Inc. Use of Alisma orientale in cosmetics and compositions thereof
EP1951260A4 (de) 2005-10-21 2009-11-11 Bezwada Biomedical Llc Funktionalisierte phenolische verbindungen und saugfähiger artikel daraus
DE102005056538A1 (de) * 2005-11-28 2007-05-31 Merz Pharma Gmbh & Co. Kgaa Zusammensetzungen, enthaltend Proteine zum Transfer / Recycling strukturell veränderter Lipide aus Biomembranen, sowie deren Anwendungen
US20080220026A1 (en) * 2007-03-06 2008-09-11 Prithwiraj Maitra Mesoporous material compositions and methods of their use for improving the appearance of biological surfaces
US7642062B2 (en) * 2006-12-29 2010-01-05 Avon Products Inc. Compositions and methods of their use for improving the condition and appearance of skin
US8217134B2 (en) 2007-08-30 2012-07-10 Bezwada Biomedical, Llc Controlled release of biologically active compounds
US8026285B2 (en) * 2007-09-04 2011-09-27 Bezwada Biomedical, Llc Control release of biologically active compounds from multi-armed oligomers
US8048980B2 (en) 2007-09-17 2011-11-01 Bezwada Biomedical, Llc Hydrolysable linkers and cross-linkers for absorbable polymers
US8053591B2 (en) * 2007-09-26 2011-11-08 Bezwada Biomedical, Llc Functionalized biodegradable triclosan monomers and oligomers for controlled release
US8367747B2 (en) 2008-05-23 2013-02-05 Bezwada Biomedical, Llc Bioabsorbable polymers from bioabsorbable polyisocyanates and uses thereof
CA2799083C (en) 2010-06-30 2018-04-24 Avon Products, Inc. Use of tiliacora triandra in cosmetics and compositions thereof
JP5850929B2 (ja) 2010-06-30 2016-02-03 エイボン プロダクツ インコーポレーテッド Ｍａｇｐ−１に刺激を与えて皮膚の外観を改善する組成物
US9259343B2 (en) 2012-07-06 2016-02-16 Newman Technologies LLC Device for mitigating plantar fasciitis
US9861645B2 (en) 2012-12-28 2018-01-09 Rak Holdings Llc Anti-itch scalp treatment compositions and combinations
WO2017074982A1 (en) 2015-10-30 2017-05-04 Patagonia Pharmaceuticals, Llc Isotretinoin formulations and uses and methods thereof
CN105816344B (zh) * 2015-12-28 2018-08-17 天津伊瑞雅生物科技有限公司 一种含有吡咯并喹啉醌和n-乙酰基神经氨酸的组合物
BE1025004B1 (nl) 2017-02-24 2018-09-24 Oystershell Nv Afpelbare nagellak
NL2035417A (en) 2022-07-19 2024-01-26 Coty Inc Cosmetic composition

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2404047A1 (de) * 1974-01-29 1975-08-14 Henkel & Cie Gmbh Hautpflege- und hautschutzmittel mit einem gehalt an haut-feuchthaltemitteln
DE2714564C2 (de) * 1977-04-01 1986-01-02 Chemische Werke Hüls AG, 4370 Marl Verfahren zur Herstellung von cyclischen Diestern der Undecandisäure
IT1114950B (it) * 1977-12-30 1986-02-03 Porro Marcella Composizioni per il trattamento e la terapia di acne
US4386104A (en) * 1977-04-19 1983-05-31 Nazzaro Porro Marcella Process for the treatment of acne
DE2936123A1 (de) * 1979-09-07 1981-04-02 Hoechst Ag, 6000 Frankfurt Verfahren zur herstellung von alkoxyessigsaeuren
US4721579A (en) * 1980-08-15 1988-01-26 Basf Corporation Sodium carboxymethyl derivatives of polyoxyalkylene glycols, their production, and use in functional fluids
US4721479A (en) * 1984-11-19 1988-01-26 Curtis Shuman Safety jumper cables
JPS62149797A (ja) * 1985-12-24 1987-07-03 花王株式会社 洗浄剤組成物
DE3640708C2 (de) * 1986-11-28 1995-05-18 Schering Ag Verbesserte metallhaltige Pharmazeutika
US5091171B2 (en) * 1986-12-23 1997-07-15 Tristrata Inc Amphoteric compositions and polymeric forms of alpha hydroxyacids and their therapeutic use
US4885282A (en) * 1987-07-02 1989-12-05 Thornfeldt Carl R Treatment of hyperhidrosis, ichthyosis and wrinkling
DE3811081A1 (de) * 1988-03-30 1989-10-12 Schering Ag Verwendung von topisch applizierbaren praeparaten zur behandlung der altershaut
US5008443A (en) * 1988-11-14 1991-04-16 Olin Corporation Process for the preparation of nitramine-containing homopolymers and co-polymers
US4916206A (en) * 1988-11-14 1990-04-10 Olin Corporation Nitramine-containing homopolymers and co-polymers and a process for the preparation thereof
DE3901279A1 (de) * 1989-01-18 1990-07-19 Hoechst Ag Verwendung von polyamidoaminen als haerter fuer epoxidharze und diese enthaltende haertbare mischungen
US5087440A (en) * 1989-07-31 1992-02-11 Salutar, Inc. Heterocyclic derivatives of DTPA used for magnetic resonance imaging
JP2876137B2 (ja) * 1989-11-29 1999-03-31 川研ファインケミカル株式会社 毛髪化粧料組成物
GB9003201D0 (en) * 1990-02-13 1990-04-11 Unilever Plc Cosmetic composition
DE4206392A1 (de) * 1992-02-29 1993-09-02 Hoechst Ag Haertungsmittel fuer epoxidharze
JPH07304653A (ja) * 1994-05-16 1995-11-21 Shiseido Co Ltd 洗浄剤組成物
US5464929A (en) * 1995-03-06 1995-11-07 Ethicon, Inc. Absorbable polyoxaesters

Also Published As

Publication number Publication date
EP0910331A1 (de) 1999-04-28
CN1139375C (zh) 2004-02-25
CA2251746A1 (en) 1997-10-30
EP0910331A4 (de) 1999-11-03
WO1997039726A1 (en) 1997-10-30
BR9708747A (pt) 2000-01-04
CN1216460A (zh) 1999-05-12
DE69730604T2 (de) 2005-09-29
JP2000510456A (ja) 2000-08-15
CA2251746C (en) 2011-04-19
US5834513A (en) 1998-11-10
DE69730604D1 (de) 2004-10-14
JP3779733B2 (ja) 2006-05-31
AR006867A1 (es) 1999-09-29
EP0910331B1 (de) 2004-09-08

Similar Documents

Publication Publication Date Title
ATE275383T1 (de) Oxadisäuren und verwandte verbindungen zur behandlung von hautstörungen
ATE280577T1 (de) Oxa-säuren und verwandte verbindungen zur behandlung von störungen der haut
DE69739303D1 (de) Vorrichtung zur thermischen behandlung von gewebe
DE69836752D1 (de) Prostaglandinagoniste und deren verwendung zur behandlung von knochenerkrankungen
DE69829921D1 (de) Vorrichtung zur Behandlung von Körpergewebe
ATE195527T1 (de) Neue steroidester zur behandlung von hauterkrankungen
DE69737402D1 (de) Vorrichtung zur Behandlung von neurodegenerativen Störungen
DE69124293D1 (de) Vorrichtung zur Behandlung von Wirbelsäulenerkrankungen
DE69412552D1 (de) Medizinisches Instrument zur Behandlung von Sinusitis
DE69827424D1 (de) Vorrichtung zur gesteuerten thermischen Behandlung von Gewebe
DE60023128D1 (de) Pyrazolecarboxamide zur behandlung von fettleibigkeit und anderen erkrankungen
DE69725339D1 (de) Vorrichtung zur diagnose und behandlung von arrhythmien
DE69918687D1 (de) 4-phenylpiperidine zur behandlung von prutitischen hauterkrankungen
DE69432299T2 (de) Multiple Botulinum Toxine zur Behandlung von neuromuskulären Störungen und Zuständen
ATA76995A (de) Stabiles präparat zur behandlung von blutgerinnungsstörungen
DE69526437D1 (de) Transdermal verabreichbare zubereitung zur behandlung von störungen des harnlassens
DE69711311T2 (de) Vorrichtung zur thermischen Behandlung von Gewebe
DE69427774D1 (de) Kontinuierliches verfahren zur behandlung von nahrungsmitteln
DE69532066D1 (de) Arzneimittel zur Behandlung von Restenosis und Gefässsklerose
DE69620691D1 (de) Therapeutisches Mittel zur Behandlung der Hypercholesterinämie
DE69807466T2 (de) Triptolid-derivate nützlich zur behandlung von autoimmunkrankheiten
DE69825319D1 (de) Präparat zur vorbeugung und behandlung von entzündungen
DE69829217D1 (de) Vorrichtung zur therapeutischen behandlung von blutgefässen
DE69519602D1 (de) Kugelförmige Aktivkohle zur Behandlung von Hämorrhoiden
ATE226071T1 (de) Antikonvulsive derivate zur behandlung von neuropathischem schmerz

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties